Becton Dickinson and Co (NYSE:BDX) over-valued by 11%
| Website | http://www.bd.com/ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Fiscal Year End | Sep 30, 2021 |
| Market Cap | $70,564,077,568 |
| Beta | 0.769442 |
| Average Volume | $1,342,357 |
| Last Dividend | 3.24% |
| Price on Aug 4, 2022 | $259.40 |
| Autochartist™ Valuation | $229.84 |
| Conclusion |
11% over-valued |
| Download Report |
